STELLA PHARMA CORPORATION
Develops boron compounds for Boron Neutron Capture Therapy (BNCT) to treat cancer.
4888 | T
Overview
Corporate Details
- ISIN(s):
- JP3399680002
- LEI:
- Country:
- Japan
- Address:
- 大阪市中央区高麗橋三丁目２番７号 ＯＲＩＸ高麗橋ビル
- Website:
- https://stella-pharma.co.jp/
- Sector:
- Manufacturing
Description
Stella Pharma Corporation is a pharmaceutical company focused on the research and development of therapeutic drugs. The company specializes in boron compounds for Boron Neutron Capture Therapy (BNCT), a form of targeted radiation therapy for cancer. As a pioneer in the field, Stella Pharma developed the boron-based drug used in the first approved BNCT treatment for unresectable head and neck cancers. Its development pipeline is focused on expanding the application of BNCT to other difficult-to-treat malignancies, with clinical trials investigating its use for conditions such as cutaneous angiosarcoma.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-14 05:26 |
確認書
|
Japanese | ZIP • 8.2 KB | ||
| 2025-11-14 05:25 |
半期報告書－第19期(2025/04/01－2026/03/31)
|
Japanese | ZIP • 202.7 KB | ||
| 2025-06-26 07:06 |
確認書
|
Japanese | ZIP • 8.1 KB | ||
| 2025-06-26 07:05 |
有価証券報告書－第18期(2024/04/01－2025/03/31)
|
Japanese | ZIP • 1.2 MB | ||
| 2025-06-26 07:05 |
内部統制報告書－第18期(2024/04/01－2025/03/31)
|
Japanese | ZIP • 21.7 KB | ||
| 2025-06-25 06:52 |
臨時報告書
|
Japanese | ZIP • 21.4 KB | ||
| 2024-11-12 05:07 |
確認書
|
Japanese | ZIP • 8.1 KB | ||
| 2024-11-12 05:06 |
半期報告書－第18期(2024/04/01－2025/03/31)
|
Japanese | ZIP • 192.3 KB | ||
| 2024-07-01 02:34 |
臨時報告書
|
Japanese | ZIP • 28.0 KB | ||
| 2024-06-28 07:05 |
内部統制報告書－第17期(2023/04/01－2024/03/31)
|
Japanese | ZIP • 21.3 KB | ||
| 2024-06-28 07:04 |
確認書
|
Japanese | ZIP • 8.1 KB | ||
| 2024-06-28 07:04 |
有価証券報告書－第17期(2023/04/01－2024/03/31)
|
Japanese | ZIP • 1.1 MB | ||
| 2024-02-14 05:13 |
四半期報告書－第17期第3四半期(2023/10/01－2023/12/31)
|
Japanese | ZIP • 145.0 KB | ||
| 2024-02-14 05:13 |
確認書
|
Japanese | ZIP • 8.1 KB | ||
| 2023-11-14 06:08 |
確認書
|
Japanese | ZIP • 8.1 KB |
Automate Your Workflow. Get a real-time feed of all STELLA PHARMA CORPORATION filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for STELLA PHARMA CORPORATION
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for STELLA PHARMA CORPORATION via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
